Cytena secures €3M in funding to advance its single-cell technology
By Nikita Chaurasia  Date: 2019-03-27

Cytena secures €3M in funding to advance its single-cell technology
  • The capital will help to broaden the sales activities of Cytena and capitalize on new applications
  • Single-cells are used in the development of biopharmaceuticals and in stem cell and cancer research

Reports confirm that High-Tech Grunderfonds (HTGF) and two private investors are going to invest another 3 million euros in Cytena GmbH. This capital will be used in developing Cytena’s single-cell printer lab technology, broaden its sales activities and promptly tap into the capabilities of new applications.

Apparently, the two private investors and High-Tech Grunderfonds (HTGF) have confidence in the significance of isolation of single-cell for the development of biopharmaceuticals as well as for genetic analysis in diagnostics and research.

Benjamin Steimle, CFO of Cytena stated that the new capital would help to understand better and serve the customer’s requirements as well as help to increase the market share of the company.

Cytena mentioned that along with way, important milestones achieved include a collaboration in sales with a vital American company and addition of x.sight devices.

In recent years, the analysis of individual biological cells has gained its importance rapidly. These single-cells are used in the development of latest drugs called biopharmaceuticals and also in stem cell and cancer research, the firm said.

Cytena’s single cell printers comprise of laboratory devices for sorting and managing individual viable cells. These instruments are considered as one of the innovative platforms for life science and offer long-term contribution towards the manufacturing and development of new drugs.

According to HTGF Investment Manager, Dr. Lena Krzyzak, investment in the Series A round helps the company to continues its successful growth in start-up financing. Dr. Krzyzak said with the company is greatly confident in its management team’s ability to expand the market and product development.

For the uninitiated, Cytena is a well-known start-up in life sciences which was founded in 2014 at the University of Freiburg, by spinning off from the Institute for Microsystems Technology (IMTEK). The Cytena team has developed the technology called the single-cell printer which enables the isolation of single cells in a gentle, sterile and documented process.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
Microsoft makes ‘carbon negative’ pledge to reach near zero emissions
By Nikita Chaurasia

Microsoft, a tech giant based in Redmond, Washington, has reportedly announced plans to go “carbon negative” by reducing carbon footprint from the atmosphere, by 2030. The technological company is placing strong emphasis on removing more...

Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
Nissan, Renault denounce split rumors following Chairman Ghosn’s exit
By Nikita Chaurasia

The automakers ensure that the alliance was not under the danger of being dissolved. Renault shares have hit six years low after the split report. Automotive giants Nissan and Renault have recently denied reports of a possible split that resulte...

Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
Visa to take over fintech firm ‘Plaid’ in $5.3 Bn acquisition deal
By Nikita Chaurasia

Visa, a financial services corporation, is reportedly acquiring Plaid, a start-up company based in San Francisco, in a deal worth $5.3 Bn. It is a long-term play that would position Visa as a leading company in the next decade and help Plaid scale it...

Dupont to invest $28Mn to produce advanced chip materials in S.Korea
Dupont to invest $28Mn to produce advanced chip materials in S.Korea
By Nikita Chaurasia

The company plans to develop a new facility in South Korea that would help reduce its dependency on Japan for semiconductor products. As Japan’s diplomatic relations with South Korea sour up, U.S. chemical company DuPont has revealed plans to...

Spotify unveils new streaming ad insertion tech to monetize podcasts
Spotify unveils new streaming ad insertion tech to monetize podcasts
By Nikita Chaurasia

Spotify Technology S.A., a Sweden based international media services provider, has reportedly announced a new podcast advertising technology called SAI (Streaming Ad Insertion) at the Consumer Electronics Show in Las Vegas. This new technology, for ...